Facilitated By

San Antonio Medical Foundation

News

  • Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer ...

    ... San Antonio Breast Cancer Symposium. MINNEAPOLIS, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology ...

  • Neoadjuvant Pembrolizumab Improves pCR Across Subgroups in ER+, HER2- Breast Cancer

    Some study authors declared affiliations with biotech, pharmaceutical, and/or device companies. ... San Antonio, TX. Abstract GS01-02. Topics: Breast ...

  • Four GOP candidates will be on the debate stage, while Trump holds a fundraiser. Follow ...

    SeaWorld San Antonio announces new water park attraction ... Tikitapu Splash features multiple water slides. Black student in Texas suspended over hair ...

  • Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk

    The work was presented in a poster spotlight discussion session at the 2023 San Antonio Breast Cancer Symposium (SABCS) on Wednesday, December 6.

  • San Antonio's Largest Construction Projects of 2024 - CoStar

    December 6, 2023 | 12:04 P.M.. As one of the fastest-growing real estate markets in the country, San Antonio is home to its fair share of construction ...